Example: quiz answers
What is in this leaflet - Medsafe
Page 1of 4 NEW ZEALAND CONSUMER MEDICINE INFORMATION CANDESTAR Candesartan cilexetil 4 mg, 8 mg, 16 mg and 32 mg tablets What is in this leaflet
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
New ACC/AHA Guideline for the Prevention, …
ish-world.comPage 13 ISH Award Funding Scheme: Continued on next page... NOT EDITED Another important novelty is that specific recommendationsare given regarding evaluation of
What Is High Blood Pressure Medicine? - heart.org
www.heart.orgLifestyle + Risk Reduction. High Blood ressure. W by. heart. What are their side effects? For many people, high blood pressure medicine can …
Evidence-based drug therapy in the management …
www.mcppnet.orgFigure 2: NICE algorithm for the treatment of heart failure (HF)1 HF HF with preserved ejection fraction HF due to left ventricular systolic dysfunction
Chronic Kidney Management of Chronic Kidney …
www.med.umich.eduThese guidelines should not be construed as including all proper methods of care or excluding other acceptable methods of care reasonably directed to obtaining the same
Interactions between antihypertensive drugs and …
www.nutricionhospitalaria.com1866 Nutr Hosp. 2012;27(5):1866-1875 ISSN 0212-1611 † CODEN NUHOEQ S.V.R. 318 Revisión Interactions between antihypertensive drugs and food B. Jáuregui-Garrido 1 and I. Jáuregui-Lobera 2
Common Cardiac Related Medications
www.whitbycardiovascular.comCommon Cardiac Related Medications Dr. Naresh Kumar & Whitby Cardiovascular Institute This reference was created by Arjun Kumar using the ‘OXFORD HANDBOOK OF PRACTICAL DRUG THERAPY’
Cardiac Failure in Children - WHO
www.who.int17th Expert Committee on the Selection and Use of Essential Medicines Geneva, March 2009 Cardiac Failure in Children Sean Beggs1 Angus Thompson2 Rose Nash2